| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | PRAMEF5 NEK6 CHD4 XPO1 PRDM5 UHRF2 DNAJA1 TP53 PRAMEF6 STAT5A STAT5B | 9.29e-06 | 582 | 74 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | transcription factor binding | PRAMEF5 NEK6 CHD4 XPO1 PRDM5 UHRF2 DNAJA1 TP53 PRAMEF6 STAT5A STAT5B | 9.76e-05 | 753 | 74 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | SUMO transferase activity | 3.19e-04 | 36 | 74 | 3 | GO:0019789 | |
| GeneOntologyCellularComponent | microtubule organizing center | ACTR8 RIC8B RPGRIP1L NEK6 GLG1 IFT81 ANKRD26 ZNF322 CHD4 TP53 SPDL1 | 2.89e-04 | 919 | 72 | 11 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | ACTR8 RIC8B RPGRIP1L NEK6 IFT81 ANKRD26 ZNF322 CHD4 TP53 SPDL1 | 2.95e-04 | 770 | 72 | 10 | GO:0005813 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.38e-04 | 96 | 72 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | chromatin | ZBTB34 NR2C1 ACTR8 PRAMEF5 TSHZ2 CHD4 KAT6B UHRF2 TRRAP GATAD2B TP53 PRAMEF6 STAT5A STAT5B | 4.58e-04 | 1480 | 72 | 14 | GO:0000785 |
| GeneOntologyCellularComponent | ATPase complex | 1.03e-03 | 129 | 72 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.04e-03 | 14 | 72 | 2 | GO:0005642 | |
| GeneOntologyCellularComponent | CHD-type complex | 1.54e-03 | 17 | 72 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | NuRD complex | 1.54e-03 | 17 | 72 | 2 | GO:0016581 | |
| MousePheno | abnormal exocrine gland morphology | NUGGC PRAMEF5 RPGRIP1L TM9SF4 UNK LAMC1 ATP8B1 SKIL DNAJA1 HELQ TP53 PRAMEF6 STAT5A STAT5B | 2.02e-05 | 853 | 63 | 14 | MP:0013558 |
| MousePheno | prolonged RR interval | 3.70e-05 | 139 | 63 | 6 | MP:0010506 | |
| MousePheno | decreased heart rate | 4.27e-05 | 288 | 63 | 8 | MP:0005333 | |
| MousePheno | absent cerebellum vermis | 5.98e-05 | 3 | 63 | 2 | MP:0000865 | |
| MousePheno | abnormal RR interval | 8.11e-05 | 160 | 63 | 6 | MP:0010504 | |
| MousePheno | abnormal spatial reference memory | 1.18e-04 | 107 | 63 | 5 | MP:0008414 | |
| MousePheno | abnormal heart rate | 1.59e-04 | 445 | 63 | 9 | MP:0001629 | |
| MousePheno | cerebellum hypoplasia | 1.65e-04 | 24 | 63 | 3 | MP:0000851 | |
| Domain | Growth_fac_rcpt_ | 3.31e-05 | 156 | 73 | 6 | IPR009030 | |
| Domain | STAT_TF_prot_interaction | 3.12e-04 | 7 | 73 | 2 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 3.12e-04 | 7 | 73 | 2 | IPR012345 | |
| Domain | STAT | 3.12e-04 | 7 | 73 | 2 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 3.12e-04 | 7 | 73 | 2 | IPR015988 | |
| Domain | - | 3.12e-04 | 7 | 73 | 2 | 2.60.40.630 | |
| Domain | STAT_int | 3.12e-04 | 7 | 73 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 3.12e-04 | 7 | 73 | 2 | IPR013801 | |
| Domain | STAT_bind | 3.12e-04 | 7 | 73 | 2 | PF02864 | |
| Domain | STAT_int | 3.12e-04 | 7 | 73 | 2 | PF02865 | |
| Domain | - | 3.12e-04 | 7 | 73 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 3.12e-04 | 7 | 73 | 2 | PF01017 | |
| Domain | - | 3.12e-04 | 7 | 73 | 2 | 1.20.1050.20 | |
| Domain | EGF | 3.14e-04 | 235 | 73 | 6 | SM00181 | |
| Domain | ARM-type_fold | 3.56e-04 | 339 | 73 | 7 | IPR016024 | |
| Domain | STAT_TF_alpha | 4.16e-04 | 8 | 73 | 2 | IPR013800 | |
| Domain | ARM-like | 6.54e-04 | 270 | 73 | 6 | IPR011989 | |
| Domain | p53-like_TF_DNA-bd | 1.17e-03 | 53 | 73 | 3 | IPR008967 | |
| Domain | EGF_CA | 1.33e-03 | 122 | 73 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.41e-03 | 124 | 73 | 4 | IPR001881 | |
| Domain | - | 1.77e-03 | 222 | 73 | 5 | 1.25.10.10 | |
| Domain | - | 1.84e-03 | 449 | 73 | 7 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 2.08e-03 | 459 | 73 | 7 | IPR013083 | |
| Domain | PUA-like_domain | 2.47e-03 | 19 | 73 | 2 | IPR015947 | |
| Domain | PRAME_family | 2.47e-03 | 19 | 73 | 2 | IPR026271 | |
| Domain | EGF-like_dom | 2.91e-03 | 249 | 73 | 5 | IPR000742 | |
| Domain | PHD | 3.16e-03 | 75 | 73 | 3 | PF00628 | |
| Domain | Znf_C2H2_jaz | 3.31e-03 | 22 | 73 | 2 | IPR022755 | |
| Domain | zf-C2H2_jaz | 3.31e-03 | 22 | 73 | 2 | PF12171 | |
| Domain | EGF-like_CS | 3.56e-03 | 261 | 73 | 5 | IPR013032 | |
| Domain | Znf_PHD-finger | 3.66e-03 | 79 | 73 | 3 | IPR019787 | |
| Domain | Znf_C2H2-like | 3.75e-03 | 796 | 73 | 9 | IPR015880 | |
| Domain | EGF_2 | 3.79e-03 | 265 | 73 | 5 | PS01186 | |
| Domain | Znf_RING_CS | 3.81e-03 | 163 | 73 | 4 | IPR017907 | |
| Domain | ZnF_C2H2 | 4.13e-03 | 808 | 73 | 9 | SM00355 | |
| Domain | cEGF | 4.61e-03 | 26 | 73 | 2 | IPR026823 | |
| Domain | cEGF | 4.61e-03 | 26 | 73 | 2 | PF12662 | |
| Domain | EGF_CA | 4.65e-03 | 86 | 73 | 3 | PF07645 | |
| Domain | PHD | 5.11e-03 | 89 | 73 | 3 | SM00249 | |
| Domain | Znf_PHD | 5.44e-03 | 91 | 73 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.13e-03 | 95 | 73 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 6.31e-03 | 96 | 73 | 3 | PS01359 | |
| Domain | EGF_Ca-bd_CS | 6.49e-03 | 97 | 73 | 3 | IPR018097 | |
| Domain | RING | 6.83e-03 | 305 | 73 | 5 | SM00184 | |
| Domain | EGF_CA | 6.87e-03 | 99 | 73 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.06e-03 | 100 | 73 | 3 | PS00010 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 2.28e-06 | 66 | 46 | 5 | M101 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.04e-04 | 5 | 46 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 1.04e-04 | 5 | 46 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 1.04e-04 | 5 | 46 | 2 | M49006 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 1.12e-04 | 29 | 46 | 3 | MM15340 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 1.24e-04 | 30 | 46 | 3 | M27637 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION | 1.37e-04 | 31 | 46 | 3 | M48258 | |
| Pathway | WP_WHITE_FAT_CELL_DIFFERENTIATION | 1.51e-04 | 32 | 46 | 3 | M39333 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.55e-04 | 6 | 46 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.55e-04 | 6 | 46 | 2 | MM15621 | |
| Pathway | WP_WHITE_FAT_CELL_DIFFERENTIATION | 1.66e-04 | 33 | 46 | 3 | MM15869 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 2.15e-04 | 36 | 46 | 3 | M542 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 2.16e-04 | 7 | 46 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 2.16e-04 | 7 | 46 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 2.16e-04 | 7 | 46 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 2.16e-04 | 7 | 46 | 2 | M47430 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 2.16e-04 | 7 | 46 | 2 | M27907 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 2.35e-04 | 271 | 46 | 6 | MM15388 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 3.10e-04 | 100 | 46 | 4 | MM14561 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 3.44e-04 | 291 | 46 | 6 | M16647 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 3.70e-04 | 9 | 46 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 3.70e-04 | 9 | 46 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 3.70e-04 | 9 | 46 | 2 | M8066 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 3.78e-04 | 191 | 46 | 5 | M29614 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 3.97e-04 | 193 | 46 | 5 | MM14890 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 4.61e-04 | 111 | 46 | 4 | M27673 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 4.61e-04 | 10 | 46 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 4.61e-04 | 10 | 46 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 4.61e-04 | 10 | 46 | 2 | MM15618 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 5.11e-04 | 204 | 46 | 5 | M4217 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 5.62e-04 | 117 | 46 | 4 | MM15387 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 5.62e-04 | 11 | 46 | 2 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 5.62e-04 | 11 | 46 | 2 | MM15578 | |
| Pathway | PID_RANBP2_PATHWAY | 5.62e-04 | 11 | 46 | 2 | M140 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 6.73e-04 | 12 | 46 | 2 | M27893 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 7.65e-04 | 127 | 46 | 4 | M27181 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 8.11e-04 | 129 | 46 | 4 | MM14894 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 8.41e-04 | 57 | 46 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 8.85e-04 | 58 | 46 | 3 | M2049 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 9.25e-04 | 14 | 46 | 2 | M27858 | |
| Pathway | PID_IL5_PATHWAY | 9.25e-04 | 14 | 46 | 2 | M135 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 9.51e-04 | 234 | 46 | 5 | MM14898 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 9.87e-04 | 236 | 46 | 5 | M27185 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 1.03e-03 | 61 | 46 | 3 | M27811 | |
| Pathway | WP_FOXP3_IN_COVID19 | 1.06e-03 | 15 | 46 | 2 | M42573 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 1.06e-03 | 15 | 46 | 2 | M552 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.06e-03 | 15 | 46 | 2 | MM1412 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.06e-03 | 15 | 46 | 2 | M17681 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 1.06e-03 | 15 | 46 | 2 | MM14536 | |
| Pathway | REACTOME_PTEN_REGULATION | 1.07e-03 | 139 | 46 | 4 | M27646 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.10e-03 | 140 | 46 | 4 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.13e-03 | 141 | 46 | 4 | MM15266 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 1.21e-03 | 16 | 46 | 2 | MM15710 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.21e-03 | 16 | 46 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.21e-03 | 16 | 46 | 2 | MM1420 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 1.21e-03 | 16 | 46 | 2 | M41733 | |
| Pathway | WP_IL9_SIGNALING | 1.37e-03 | 17 | 46 | 2 | M39644 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.37e-03 | 17 | 46 | 2 | M47905 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 1.40e-03 | 68 | 46 | 3 | M39456 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 1.54e-03 | 18 | 46 | 2 | M673 | |
| Pathway | REACTOME_DEUBIQUITINATION | 1.57e-03 | 262 | 46 | 5 | MM15286 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 1.66e-03 | 72 | 46 | 3 | M39738 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.72e-03 | 158 | 46 | 4 | MM14791 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 1.72e-03 | 19 | 46 | 2 | M41732 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 1.72e-03 | 19 | 46 | 2 | M12836 | |
| Pathway | KEGG_CHRONIC_MYELOID_LEUKEMIA | 1.72e-03 | 73 | 46 | 3 | M321 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.85e-03 | 272 | 46 | 5 | M29619 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 1.91e-03 | 20 | 46 | 2 | MM15496 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 1.91e-03 | 20 | 46 | 2 | MM1389 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 1.91e-03 | 20 | 46 | 2 | M39002 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 2.10e-03 | 21 | 46 | 2 | M27634 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | 2.11e-03 | 561 | 46 | 7 | M5336 | |
| Pathway | REACTOME_M_PHASE | 2.22e-03 | 417 | 46 | 6 | M27662 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 2.31e-03 | 22 | 46 | 2 | M7747 | |
| Pathway | PID_REG_GR_PATHWAY | 2.40e-03 | 82 | 46 | 3 | M115 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.49e-03 | 175 | 46 | 4 | MM14941 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 2.52e-03 | 23 | 46 | 2 | MM1411 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 2.52e-03 | 23 | 46 | 2 | MM1424 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 2.52e-03 | 23 | 46 | 2 | M7897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 2.52e-03 | 23 | 46 | 2 | M47904 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 2.60e-03 | 177 | 46 | 4 | M27476 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 2.75e-03 | 24 | 46 | 2 | M11520 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 2.75e-03 | 24 | 46 | 2 | M519 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 2.87e-03 | 301 | 46 | 5 | MM15983 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 2.98e-03 | 25 | 46 | 2 | M41829 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 2.98e-03 | 25 | 46 | 2 | MM1519 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 2.98e-03 | 25 | 46 | 2 | M27865 | |
| Pathway | WP_IL7_SIGNALING | 2.98e-03 | 25 | 46 | 2 | M39499 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 3.22e-03 | 26 | 46 | 2 | M27750 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 3.22e-03 | 26 | 46 | 2 | M39687 | |
| Pathway | PID_IL3_PATHWAY | 3.22e-03 | 26 | 46 | 2 | M182 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 3.22e-03 | 26 | 46 | 2 | MM15896 | |
| Pathway | REACTOME_SUMOYLATION | 3.29e-03 | 189 | 46 | 4 | M27214 | |
| Pathway | WP_ERBB_SIGNALING | 3.33e-03 | 92 | 46 | 3 | M39715 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 3.40e-03 | 313 | 46 | 5 | M27867 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 3.42e-03 | 191 | 46 | 4 | MM15289 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 3.44e-03 | 93 | 46 | 3 | M27572 | |
| Pathway | REACTOME_SIGNALING_BY_ALK_IN_CANCER | 3.44e-03 | 93 | 46 | 3 | M42521 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 3.47e-03 | 27 | 46 | 2 | MM15537 | |
| Pathway | BIOCARTA_GH_PATHWAY | 3.47e-03 | 27 | 46 | 2 | M9043 | |
| Pubmed | NR2C1 ZNF334 ZNF423 UNK ZNF322 KAT6B SKIL PRDM5 UHRF2 GATAD2B TP53 STAT5A STAT5B | 2.07e-08 | 808 | 76 | 13 | 20412781 | |
| Pubmed | Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. | 4.00e-08 | 4 | 76 | 3 | 14607901 | |
| Pubmed | BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. | 4.00e-08 | 4 | 76 | 3 | 21593872 | |
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 21911423 | ||
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 29794014 | ||
| Pubmed | 2.00e-07 | 6 | 76 | 3 | 23852341 | ||
| Pubmed | Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development. | 3.49e-07 | 7 | 76 | 3 | 24463518 | |
| Pubmed | 5.57e-07 | 8 | 76 | 3 | 23727894 | ||
| Pubmed | NR2C1 ACTR8 PPP2R5E ZNF334 ZNF423 IFT81 PSMD1 CHD4 KDM6B SKIL DNAJA1 LRP1B COG4 STAT5B | 6.65e-07 | 1285 | 76 | 14 | 35914814 | |
| Pubmed | 8.34e-07 | 9 | 76 | 3 | 19946273 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 8.47e-07 | 146 | 76 | 6 | 23892456 | |
| Pubmed | 1.19e-06 | 10 | 76 | 3 | 32103006 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 2.68e-06 | 178 | 76 | 6 | 27637333 | |
| Pubmed | 3.73e-06 | 560 | 76 | 9 | 35241646 | ||
| Pubmed | 4.54e-06 | 195 | 76 | 6 | 19454010 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23151802 | ||
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 4.71e-06 | 2 | 76 | 2 | 31443474 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 38580756 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 33208462 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 4.71e-06 | 2 | 76 | 2 | 21127177 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16289657 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25470773 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 4.71e-06 | 2 | 76 | 2 | 21431790 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 7720707 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12217382 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31599926 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10594041 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21036145 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10486277 | ||
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 4.71e-06 | 2 | 76 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 4.71e-06 | 2 | 76 | 2 | 30377054 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23565285 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 4.71e-06 | 2 | 76 | 2 | 23773921 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 4.71e-06 | 2 | 76 | 2 | 24878107 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 7568026 | ||
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 4.71e-06 | 2 | 76 | 2 | 10486314 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24335105 | ||
| Pubmed | Brain STAT5 signaling modulates learning and memory formation. | 4.71e-06 | 2 | 76 | 2 | 29460051 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28606561 | ||
| Pubmed | Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. | 4.71e-06 | 2 | 76 | 2 | 12393407 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21178171 | ||
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 4.71e-06 | 2 | 76 | 2 | 20233708 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17447893 | ||
| Pubmed | An Unbiased Linkage Approach Reveals That the p53 Pathway Is Coupled to NK Cell Maturation. | 4.71e-06 | 2 | 76 | 2 | 28710252 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 27013579 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16115927 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11867689 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 15340066 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16532027 | ||
| Pubmed | Role of Stat5 in type I interferon-signaling and transcriptional regulation. | 4.71e-06 | 2 | 76 | 2 | 12901872 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25333863 | ||
| Pubmed | A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. | 4.71e-06 | 2 | 76 | 2 | 12421978 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19966185 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21704724 | ||
| Pubmed | Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. | 4.71e-06 | 2 | 76 | 2 | 8732682 | |
| Pubmed | The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5. | 4.71e-06 | 2 | 76 | 2 | 32281944 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23465551 | ||
| Pubmed | DNAJA1 promotes cancer metastasis through interaction with mutant p53. | 4.71e-06 | 2 | 76 | 2 | 34183772 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 27367207 | ||
| Pubmed | Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. | 4.71e-06 | 2 | 76 | 2 | 16493008 | |
| Pubmed | Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors. | 4.71e-06 | 2 | 76 | 2 | 15677477 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16757175 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 15677453 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17317776 | ||
| Pubmed | The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients. | 4.71e-06 | 2 | 76 | 2 | 32041920 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17976521 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25896118 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22319210 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28600321 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10428030 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 26999798 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12377952 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25552366 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28500076 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21826656 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 4.71e-06 | 2 | 76 | 2 | 27264955 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22159083 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20008792 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 33199496 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16502315 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 35694386 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 4.71e-06 | 2 | 76 | 2 | 16840779 | |
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 4.71e-06 | 2 | 76 | 2 | 32790723 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 18492722 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10066807 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10835485 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 35464049 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21483786 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 18286195 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 4.71e-06 | 2 | 76 | 2 | 11030348 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12847485 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12835478 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 4.71e-06 | 2 | 76 | 2 | 24497979 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 4.71e-06 | 2 | 76 | 2 | 17382296 | |
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 4.71e-06 | 2 | 76 | 2 | 17911616 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17599554 | ||
| Pubmed | MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation. | 4.71e-06 | 2 | 76 | 2 | 24497923 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12039059 | ||
| Interaction | HDAC1 interactions | NR2C1 RANBP2 ACTR8 ZNF423 PSMD1 CHD4 XPO1 SKIL PRDM5 UHRF2 DNAJA1 COG4 GATAD2B TP53 POLR3A STAT5A SPDL1 | 3.97e-07 | 1108 | 74 | 17 | int:HDAC1 |
| Interaction | NANOG interactions | ZBTB34 RANBP2 PPP2R5E PSMD1 CHD4 DNAJA1 TRRAP CRBN GATAD2B TP53 | 1.00e-05 | 481 | 74 | 10 | int:NANOG |
| Interaction | ANKRD36C interactions | 1.02e-05 | 12 | 74 | 3 | int:ANKRD36C | |
| Interaction | RUVBL2 interactions | ACTR8 NEK6 PSMD1 CHD4 XPO1 PPP6R2 DNAJA1 TRRAP CRBN TP53 POLR3A | 1.45e-05 | 616 | 74 | 11 | int:RUVBL2 |
| Interaction | KPNA4 interactions | 1.88e-05 | 225 | 74 | 7 | int:KPNA4 | |
| Interaction | POLD3 interactions | 3.03e-05 | 98 | 74 | 5 | int:POLD3 | |
| Interaction | KDM1A interactions | NR2C1 RANBP2 RPGRIP1L UNK LAMC1 PSMD1 CHD4 XPO1 DNAJA1 TRRAP CRBN TP53 SPDL1 | 3.42e-05 | 941 | 74 | 13 | int:KDM1A |
| Interaction | EPAS1 interactions | 4.19e-05 | 173 | 74 | 6 | int:EPAS1 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | 1.66e-06 | 196 | 76 | 7 | M9243 | |
| ToppCell | facs-Thymus-Epithelium-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-06 | 110 | 76 | 5 | 3a641dced828ed97a8eea70d0a7b76f33630c9be | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 3.94e-06 | 197 | 75 | 7 | 2306_DN | |
| Disease | colon adenocarcinoma (is_implicated_in) | 3.34e-05 | 26 | 71 | 3 | DOID:234 (is_implicated_in) | |
| Disease | gastric adenocarcinoma (is_marker_for) | 4.19e-05 | 28 | 71 | 3 | DOID:3717 (is_marker_for) | |
| Disease | malaria | 1.09e-04 | 102 | 71 | 4 | EFO_0001068 | |
| Disease | colorectal cancer (is_implicated_in) | 2.11e-04 | 121 | 71 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Ductal Carcinoma | 3.10e-04 | 11 | 71 | 2 | C1176475 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 3.10e-04 | 11 | 71 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | non-high density lipoprotein cholesterol measurement | 3.11e-04 | 713 | 71 | 8 | EFO_0005689 | |
| Disease | T-Cell Lymphoma | 6.70e-04 | 16 | 71 | 2 | C0079772 | |
| Disease | carotid artery intima media thickness | 7.55e-04 | 450 | 71 | 6 | EFO_0007117 | |
| Disease | Hypertriglyceridemia | 9.51e-04 | 19 | 71 | 2 | EFO_0004211 | |
| Disease | Granulomatous Slack Skin | 1.28e-03 | 22 | 71 | 2 | C0376407 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 1.40e-03 | 23 | 71 | 2 | C0079773 | |
| Disease | Disorder of eye | 1.73e-03 | 212 | 71 | 4 | C0015397 | |
| Disease | corpus callosum volume measurement | 1.83e-03 | 100 | 71 | 3 | EFO_0010299 | |
| Disease | Vitiligo | 1.88e-03 | 101 | 71 | 3 | EFO_0004208 | |
| Disease | colorectal adenocarcinoma (is_marker_for) | 1.93e-03 | 27 | 71 | 2 | DOID:0050861 (is_marker_for) | |
| Disease | suntan | 1.99e-03 | 103 | 71 | 3 | EFO_0004279 | |
| Disease | Ciliopathies | 2.40e-03 | 110 | 71 | 3 | C4277690 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLQQCCVIFDFMDTL | 66 | Q16537 | |
| ECQLTNKMDCLLLQH | 331 | Q9H981 | |
| DKLLNNCLLSCTMQE | 401 | Q9H9E3 | |
| ELDIMNKCTSLCCKQ | 311 | Q96SW2 | |
| FVINEVCEMKNCNKC | 101 | Q8TDN6 | |
| LMKIKDNINCLFQHC | 71 | Q5T2E6 | |
| NTMEKCIEKQERFCQ | 1146 | Q8N2N9 | |
| SDKKEMLQQCFCIIG | 141 | Q9H8G2 | |
| MLQQCFCIIGEKKLQ | 146 | Q9H8G2 | |
| ALMKAVQCQEEKCAT | 116 | Q9UPS8 | |
| CMDIQLVEALCGFQK | 261 | P31689 | |
| QNIMTFKKCCINGQI | 461 | O43520 | |
| LNSLMVKCPAKECNE | 351 | P15918 | |
| DCFKKTFEECQQNLM | 3031 | P49792 | |
| KLQEFCNSMVKLCID | 481 | P13056 | |
| DCQECMKKFISANQL | 321 | Q9NQX1 | |
| EKLCQQKYNVSCIMI | 846 | Q8WYB5 | |
| MVDVKCLSDCKLQNQ | 1 | Q68G75 | |
| NTMEKCIEKQERFCQ | 1571 | Q5JPF3 | |
| EFACSNKKCIPMDLQ | 3766 | Q9NZR2 | |
| EKHDQCKCENLIMFQ | 911 | O00339 | |
| DELNMQLKEQRLKCC | 311 | Q68CZ1 | |
| KGMAKLCQQQETICI | 1861 | Q6PRD1 | |
| YNNQCTMCKAKLERE | 736 | Q9NQ38 | |
| DKTCKAFQICAIMNL | 421 | Q92484 | |
| IKFCLLQSMKHCQVQ | 1536 | O15054 | |
| KQCRDQFKDMNKSCD | 141 | Q9BX97 | |
| NKSCDALLFMLNQKV | 151 | Q9BX97 | |
| KMNLFSLCQKIEQCD | 251 | Q9HC98 | |
| LNAKMEECVKLNCEQ | 576 | Q9NZV8 | |
| NKMFCQLAKTCPVQL | 131 | P04637 | |
| NGKILCEQCMTSNQK | 436 | Q8WXI9 | |
| CEQCMTSNQKKALKA | 441 | Q8WXI9 | |
| GFMDDCKNDINILKC | 236 | Q92896 | |
| LLQNTCLDCEKMAAL | 416 | A4D1B5 | |
| MECKKQCFLKQQSQT | 646 | Q8WYA0 | |
| KMHKLLQQARQCCDE | 326 | P10911 | |
| KLQCNRLMPNSQKDC | 776 | Q69YH5 | |
| MKNEFDKLVCNCKHN | 296 | P11047 | |
| SKKNCENVAEMICKF | 586 | Q8TDG4 | |
| NNLDKDCDNMKDPCF | 61 | P82279 | |
| VSLLNVVMDLKKCCN | 1006 | Q14839 | |
| CFQSETKFKMTVCQL | 96 | Q5GAN4 | |
| NQKLLDFLCRQQCME | 41 | O75170 | |
| LQCLKVLFVNMNCLT | 116 | A6NM36 | |
| LLEKAIAQCFACMEQ | 501 | Q68CJ6 | |
| KLEQIMKQKCTCDSN | 606 | P12757 | |
| CCMEKSNKINENKRF | 1151 | B5MCY1 | |
| ESLKCLCNIVFNSQM | 116 | Q9NVN3 | |
| SCLKVQEQMANCPKF | 116 | Q96A37 | |
| MNLEKPDFINVCQCL | 206 | Q99460 | |
| TCCHIMLSQEEKKQF | 111 | O14802 | |
| LSCECEAIKQQQKMH | 76 | Q96EA4 | |
| DFCMDKVNFCQEKLE | 151 | Q5VXU9 | |
| QLCEALNMKFKAEVQ | 506 | P51692 | |
| QLCEALNMKFKAEVQ | 506 | P42229 | |
| NCISTCEQIKDKYMQ | 431 | Q9UKZ1 | |
| QVCFLLKLMLQQCKT | 1601 | Q96JI7 | |
| PNFLKKLEQSFMCVC | 721 | Q96PU4 | |
| TTQFLKLCCLQKLSM | 261 | Q5VXH4 | |
| KLCCLQKLSMNSVSF | 266 | Q5VXH4 | |
| QDMACDTFIKIAQKC | 581 | O14980 | |
| CLALCAKLEQFTTMN | 91 | Q9H2L4 | |
| QCKRMNTKENLYECS | 506 | Q9HCZ1 | |
| QVLMNSEKKCEVLCS | 91 | Q92544 | |
| KNCQCSPAKAKNMIL | 76 | P50443 | |
| TTQFLKLCCLQKLSM | 261 | Q5TYX0 | |
| KLCCLQKLSMNSVSF | 266 | Q5TYX0 | |
| LECKQNFCENLALIM | 46 | Q6U7Q0 | |
| ELEYNCQMCKQKSCV | 481 | Q9HBJ7 | |
| CMDNNKHCKQDNCLL | 471 | P49746 | |
| MCEKHNQFLTLFCVK | 96 | Q495X7 | |
| QFEACKSQILKCMEC | 371 | Q9NRE2 | |
| QSFPCCQNMKEKFNK | 361 | P37288 | |
| MECQNSSLKKCLLVE | 811 | O95789 | |
| KTYQCIKCQMTFENE | 1166 | Q2M1K9 | |
| KLCNQMFDSPAKLLC | 1201 | Q2M1K9 | |
| EQRLEMCCLSKLQDK | 191 | Q504Y3 | |
| VFHMQSVKCLKCQEQ | 761 | Q9C0B0 | |
| CQFEEMKICSAIINL | 1506 | Q9Y4A5 | |
| ASFLQMQCVIDKCTQ | 106 | Q8NCN2 | |
| KDLCSQQKQEDICMG | 481 | Q7Z570 |